Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus ...
Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus ...
At a 9-month angiographic follow-up, there was no significant difference in LL between the Element and Express stents (0.34 ± 0.55 mm vs 0.26 ± 0.52 mm; p = 0.33). Although the noninferiority ...